Dataset: Frontotemporal dementia; Splicing; TDP-43; Transcriptomics. - PathMap Experiment #000067

Engineering notes

Cell-Type Specificity:** Transcriptomic profiles vary significantly between FTD subtypes and glial populations (oligodendrocytes vs.

Chinese explanation / 中文解读

中文解读待补充：本站会优先为端到端自动驾驶、BEV感知、3D目标检测、轨迹预测、路径规划、LiDAR感知等高价值论文补充中文说明。

Original abstract

Interactive Data Viewer: Read, View, and Print from Day 1 Use our fully interactive viewer to view, read, and print this research data right from Day 1: https://pathmap.org/viewer.php?id=67 Artificial General Intelligence LLC Claim Evaluated: Frontotemporal dementia; Splicing; TDP-43; Transcriptomics. This dataset contains the raw JSON execution trace, verified verbatim quotes, and MeSH-aligned logic gates generated by PathMap Studio's Veridical Enforcement engine. 🔍 Novel & Overlooked Insights Glial cells, particularly oligodendrocytes and astrocytes, exhibit more diverse splicing profiles than neurons in the human cortex. The C9orf72 repeat expansion promotes the retention of an extended exon 1 rather than previously assumed models of DPR protein biogenesis. TDP-43 functions as a repressor of paraspeckle formation, linking its polymerization state to neuroprotective condensation. RNA G-quadruplex-protein homeostasis is critical, as its failure transforms protective condensates into irreversible aggregates. The decapping scavenger enzyme (DCPS) acts as a genetic modifier of TDP-43 loss-of-function neurotoxicity. TDP-43 phosphorylation can alter fibril conformation in vitro, despite soluble phosphomimetic proteins maintaining similar structures to wild-type. Iron accumulation in the temporal cortex is a non-invasive MRI marker that correlates with TDP-43-associated disease progression. Cryptic Exon Biology:** Splicing repression of cryptic exons by TDP-43 is a central pathogenic event. Target Diversity:** TDP-43 regulates diverse targets including genes for synaptic membrane excitability (KALRN, KCNQ2). RBP Networks:** The hnRNP network, including hnRNP K, works in concert with TDP-43 to regulate transcripts like DNAJC5. Cell-Type Specificity:** Transcriptomic profiles vary significantly between FTD subtypes and glial populations (oligodendrocytes vs. astrocytes). Mitochondrial Impact:** TDP-43 loss directly leads to aberrant splicing of UQCRC2, impacting respiratory capacity. DNA Repair:** Impaired interaction with the DNA damage response (DDR) machinery is a consequence of TDP-43 dysfunction. Proteostasis Failure:** P-body regulation and DCPS activity are modulated by TDP-43 levels, creating a link between splicing and RNA decay. Myelination Crosstalk:** Neuronal TDP-43 modulates myelin formation through NRXN1 mRNA stabilization. Glial cells, specifically oligodendrocytes and microglia, exhibit higher isoform diversity than neurons in the human cortex, suggesting they are primary targets for splicing-mediated pathology. The "Molecular Zipper" hypothesis posits that the N-terminal domain acts as an anchor to maintain TDP-43 in a functional dimeric state, and its "unzipping" triggers aggregation. Cryptic exon inclusion occurs selectively in neurons displaying TDP-43 pathology and acts as a direct driver of neuronal dysfunction. TDP-43 loss-of-function leads to the accumulation of specific truncated proteins, such as the DAP12 protein, which impairs TREM2 signaling in microglia. Transcriptomic profiles in FTLD-TDP pathological subtypes reveal that glial clusters are more strongly associated with RNA-processing dysfunction than previously recognized. Progranulin insufficiency interacts with TDP-43 expression to worsen neuroinflammatory responses without necessarily inducing aggregates, suggesting non-aggregative mechanisms of disease progression. The hnRNP network is fundamentally altered in FTLD-TDP, suggesting that TDP-43 operates within a broader, vulnerable RNA-binding protein landscape. 🧪 Extracted Custom Datapoints 📊 Suggested Experiments Perform single-cell long-read transcriptomics in iPSC-derived FTD neurons to correlate specific cryptic exon events with localized translational outcomes. Investigate the impact of DCPS inhibition on P-body morphology and neuronal survival in patient-derived neuronal models of FTD. Assess the efficacy of ASOs targeting specific cryptic exons (e.g., KALRN, UQCRC2) in human iPSC-derived FTD models. Evaluate the rescue potential of restoring KIAA1324 protein levels in neurons with pathological TDP-43. Assess the effect of IRE1 activation on the frequency of cryptic exon inclusion in FTD patient-derived iPSCs. Perform single-cell transcriptomics on oligodendrocytes from FTD-TDP patients to map the longitudinal progression of isoform diversity loss. Utilize antisense oligonucleotides (ASOs) to target the specific cryptic exons identified in the Tyrobp or STMN2 transcripts in vivo to observe motor improvement. 📊 Suggested Studies Longitudinal analysis of serum TDP-43 functional activity and cryptic exon markers in at-risk carriers of GRN/C9orf72 mutations. Comprehensive proteomic profiling of glial vs neuronal compartments in FTLD-TDP types A, B, and C. Longitudinal analysis of cryptic exon inclusion across disease stages in FTD patient-derived organoids. Spatial transcriptomic profiling to correlate specific splicing signatures with glial damage in sporadic FTD. A meta-analysis comparing isoform-specific transcriptomic signatures across sporadic vs. familial FTLD-TDP subtypes. A longitudinal cohort study evaluating the correlation between CSF TDP-43 dSAA seed levels and cryptic exon inclusion ratios in patients. Comparative analysis of glial-specific RNA-processing dysfunction in FTLD-TDP vs. other neurodegenerative proteinopathies. 📊 Swansons Literature Based Discovery Candidates {"Discovered Hypothesis (A to C)":"Iron accumulation in the temporal cortex modulates TDP-43 nuclear export via oxidative stress, exacerbating splicing dysregulation.","Literature A (Origin)":"Iron accumulation in FTLD (ID 42208872)","Literature C (Target)":"TDP-43-dependent splicing dysregulation (ID 41120750)","The Intersecting Bridge B":"Oxidative stress\/ROS (ID 42244572)","Biological Rationale":"ROS produced by metabolic\/oxidative stress facilitates TDP-43 cysteine oxidation, which is known to promote nuclear export, thereby depleting the nucleus of TDP-43 and causing cryptic splicing."} • Discovered Hypothesis (A to C): Inhibition of P-body hyperactivation by DCPS knockdown restores mitochondrial respiration via UQCRC2 splicing regulation in TDP-43 depleted neurons. - Literature A (Origin): ID 41943580 (DCPS modulates TDP-43-linked neurodegeneration through P-body-mediated RNA decay). - Literature C (Target): ID 41761273 (TDP-43-driven alternative splicing of UQCRC2 modulates mitochondrial bioenergetics). - The Intersecting Bridge B: TDP-43-regulated RNA homeostasis. - Biological Rationale: TDP-43 loss-of-function leads to both P-body dysregulation (causing aberrant RNA decay) and specific aberrant splicing of nuclear-encoded mitochondrial genes like UQCRC2. Stabilizing P-body dynamics through DCPS inhibition may preserve the RNA integrity required for accurate UQCRC2 splicing. • Discovered Hypothesis (A to C): [TDP-43 splicing-mediated loss of mitochondrial homeostasis contributes to FTD-TDP cell death through altered metabolic signaling.] - Literature A (Origin): [TDP-43 loss-of-function splicing repression (ID: 42234776)] - Literature C (Target): [Mitochondrial dysfunction linked to ALS/FTD (ID: 42399370)] - The Intersecting Bridge B: [STMN2 and RNA-decay pathways (ID: 42343570)] - Biological Rationale: [TDP-43 loss leads to STMN2 depletion which is essential for microtubule stability, and combined with disrupted mitochondrial localization, the resulting metabolic crisis accelerates neuronal atrophy.] 📊 Contradictions Between Evidences Conflicting perspectives exist on the pathogenicity of cytoplasmic TDP-43 fragments vs. nuclear loss of function, with some models suggesting gain-of-toxicity and others emphasizing nuclear loss as the primary driver. None identified within the provided context; evidence consistently supports the central role of TDP-43 loss-of-function in driving splicing-mediated neurodegeneration. There is a slight conflict regarding whether STMN2 depletion is solely TDP-43 dependent; ID 42343570 argues it is independent of TDP-43 splicing loss under acute stress, while others cite it as a canonical TDP-43 splicing target. 📊 Repurposed Solutions Repurposing of posaconazole and other azole-based CYP51 inhibitors is suggested to mitigate TDP-43 mislocalization by lowering cellular cholesterol and activating autophagy. GSK3 inhibitors (CHIR99021) and DCPS modulators are proposed as strategies to restore TDP-43 proteostasis and prevent its fragmentation/aggregation, directly addressing the splicing-mediated downstream toxicity. Small molecules targeting the conserved α-helical region (CR) of TDP-43 (e.g., XL20) can restore mitochondrial function without altering canonical splicing activity, offering a potential therapeutic avenue for FTD. Tags Attractor Table Extracted Keywords & Entities DNA-Binding Protein-43, _gates_from_dna-binding_protein-43, RNA Splicing, _gates_to_rna_splicing, _gates_from_rna_splicing, Neuronal dysfunction, _gates_to_neuronal_dysfunction, Exons, _gates_to_exons, Splicing defects, _gates_from_splicing_defects, Frontotemporal Dementia, _gates_to_frontotemporal_dementia, _gates_from_exons, Protein Isoforms, _gates_to_protein_isoforms, _gates_from_protein_isoforms, Neurodegeneration, _gates_to_neurodegeneration Run Your Own Analysis PathMap is a patent-pending universal AI workbench designed to eliminate LLM hallucinations in medical research. Generate your own autonomous discovery reports at PathMap.org.

Links and sources

Comments